543 related articles for article (PubMed ID: 19549395)
1. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].
Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395
[TBL] [Abstract][Full Text] [Related]
2. Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Piñana JL; Valcárcel D; Martino R; Barba P; Moreno E; Sureda A; Vega M; Delgado J; Briones J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Jan; 15(1):21-9. PubMed ID: 19135939
[TBL] [Abstract][Full Text] [Related]
3. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors.
Hingorani SR; Guthrie K; Batchelder A; Schoch G; Aboulhosn N; Manchion J; McDonald GB
Kidney Int; 2005 Jan; 67(1):272-7. PubMed ID: 15610251
[TBL] [Abstract][Full Text] [Related]
4. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Yu ZP; Ding JH; Chen BA; Liu BC; Liu H; Li YF; Ding BH; Qian J
Chin J Cancer; 2010 Nov; 29(11):946-51. PubMed ID: 20979694
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
[TBL] [Abstract][Full Text] [Related]
9. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
[TBL] [Abstract][Full Text] [Related]
10. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant.
Parikh CR; McSweeney P; Schrier RW
Kidney Int; 2005 May; 67(5):1999-2005. PubMed ID: 15840050
[TBL] [Abstract][Full Text] [Related]
11. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia.
Liu H; Ding JH; Liu BC; Zhao G; Chen BA
Am J Nephrol; 2007; 27(4):336-41. PubMed ID: 17519537
[TBL] [Abstract][Full Text] [Related]
12. [Allogeneic stem cell transplantation for 75 cases of acute myeloid leukemia in complete remission: outcome and prognostic analysis].
Song AX; Yang DL; Wei JL; Yan ZS; Wang M; Jiang EL; Huang Y; Liu QG; Ma QL; Zhai WH; Zhang RL; Feng SZ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):161-6. PubMed ID: 20137139
[TBL] [Abstract][Full Text] [Related]
13. [Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation].
Ma XJ; Ren HY; Qiu ZX; Cen XN; Ou JP; Wang WS; Xu WL; Wang LH; Dong YJ; Sun YH; Li Y; Yin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1007-12. PubMed ID: 20723318
[TBL] [Abstract][Full Text] [Related]
14. [A clinical study of allo-hematopoietic stem cell transplantation in HBsAg positive leukemia].
Chen Y; Xu LP; Liu KY; Liu DH; Han W; Chen H; Zhang YC; Chen YH; Huang XJ
Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):316-9. PubMed ID: 18843958
[TBL] [Abstract][Full Text] [Related]
15. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
16. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
[TBL] [Abstract][Full Text] [Related]
18. [A retrospective study of kidney insufficiency in adult patients after myeloablative allogeneic hematopoietic stem cell transplantation].
Luo CW; DU X; Weng JY; Wu SJ; Guo R; Lu ZS; Ling W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):671-5. PubMed ID: 22739180
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
20. Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and relationship with the quantity of transplanted cells.
Tokgoz B; Kocyigit I; Polat G; Eser B; Unal A; Kaynar L; Sipahioglu MH; Oymak O; Utas C; Cetin M
Ren Fail; 2010 Jun; 32(5):547-54. PubMed ID: 20486836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
